Westpac Banking Corp’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-105,448
Closed -$1.71M 832
2022
Q1
$1.71M Buy
105,448
+2,360
+2% +$60.5K 0.02% 603
2021
Q4
$4.89M Buy
103,088
+29,864
+41% +$1.79M 0.05% 409
2021
Q3
$5.31M Buy
+73,224
New +$5.3M 0.06% 409

Other funds holding NBP

Westpac Banking Corp's NBP Position: Q2 2022 in Review

Westpac Banking Corp sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 105,448 shares — an estimated $1.71M sold.

Westpac Banking Corp first reported a position in NBP in Q3 2021 and held it in 3 quarters. The position peaked at $5.31M in Q3 2021. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

  • Westpac Banking Corp reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Westpac Banking Corp sold 105,448 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $1.71M.
  • Westpac Banking Corp first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2021 and held it in 3 quarters.
  • Westpac Banking Corp's NovaBridge Biosciences American Depositary Shares position peaked at $5.31M in Q3 2021.
  • 97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on Westpac Banking Corp's 13F filing for Q2 2022, filed 10 Aug 2022.